Skip to main content

Table 6 Subgroup analysis of response rate of SJZT or MSJZT in patients with FD

From: Efficacy and safety of Si-Jun-Zi-Tang-based therapies for functional (non-ulcer) dyspepsia: a meta-analysis of randomized controlled trials

  Subgroups No. of trials No. of patients Pooled RR
(95% CI); P-value
Pheterogeneity; I2
All studies   12 1383 1.23 (1.17, 1.30); P < 0.00001 0.03; 47%
Intervention in trial group SJZT 1 90 1.21 (0.99, 1.49); P = 0.06 Not applicable
MSJZT 8 988 1.24 (1.16, 1.34); P < 0.00001 0.20; 29%
SJZT + conventional medicines 2 245 1.17 (0.81, 1.68); P = 0.40 0.009; 85%
MSZT + conventional medicines 1 60 1.22 (0.98, 1.52); P = 0.08 Not applicable
Intervention in control group Placebo 2 118 1.74 (1.30, 2.34); P = 0.0002 0.34; 0%
Conventional medicines 10 1265 1.20 (1.15, 1.26); P < 0.00001 0.21; 25%
  1. RR relative risk, CI confidence interval